Finance News – Pharmaceutical Industry
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Eli Lilly ramps up UK price of weight loss jab Mounjaro after Trump demands
Eli Lilly’s planned increase in the UK cost for its obesity medication reflects a strategic adjustment influenced by US political pressure, potentially affecting affordability and...
Read Full Article →Trump threatens drugmakers with 250% tariffs. Here’s when higher levies could come.
The proposed increase in tariffs on pharmaceutical companies could substantially impact industry costs and pricing strategies if implemented in the near future.
Read Full Article →Trump’s 15% tariff on medicines will harm patients, say EU drugmakers
The introduction of a 15% import duty on European medicines is expected to increase costs, disrupt supply chains, and negatively impact pharmaceutical companies' market valuations...
Read Full Article →ABPI: UK aims high on life sciences, but investment lags behind
The UK government's plan to become a global life sciences leader by 2030 faces financial challenges as current investment levels and funding reforms may be insufficient to meet the...
Read Full Article →Weight loss drugs are squeezing the food industry
The rapid success of GLP-1 medications is driving substantial revenue growth for pharmaceutical companies while simultaneously reducing consumer spending and demand within the food...
Read Full Article →Trump signs order aiming to cut some U.S. drug prices to match lower ones abroad
The executive action seeks to reduce prescription medication costs by aligning U.S. prices with those in other countries, potentially impacting pharmaceutical companies amid upcomi...
Read Full Article →